NCT06260865 is a NA clinical trial of MORA Cure in Patellofemoral Pain Syndrome, sponsored by EverEx Inc..

Who is sponsoring NCT06260865?

NCT06260865 is sponsored by EverEx Inc..

What drugs are being tested in NCT06260865?

Interventions in NCT06260865: MORA Cure, Treatment as Usual.

What condition does NCT06260865 study?

NCT06260865 studies Patellofemoral Pain Syndrome.

Is NCT06260865 still recruiting?

NCT06260865 is currently active, enrolled. Last updated 23 January 2025.

Last reviewed 2025-01-23 · How we verify

NCT06260865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome

Active, enrolled NA Last updated 23 January 2025

What this trial tests

NA trial testing MORA Cure in Patellofemoral Pain Syndrome in 216 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

26 April 2024

Primary endpoint
31 March 2025

31 March 2025

Quick facts

Lead sponsor	EverEx Inc.
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	216
Start date	26 April 2024
Primary completion	31 March 2025
Estimated completion	31 March 2025
Sites	10 locations across South Korea

Drugs / interventions tested

MORA Cure
Treatment as Usual

Conditions studied

Patellofemoral Pain Syndrome — all drugs for Patellofemoral Pain Syndrome →

Sponsor

EverEx Inc. — full company profile →

Who can join

Eligibility, any sex, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled confirmatory study will be evaluating an mobile application, MORA Cure (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Study protocol for a prospective, randomized controlled confirmatory clinical investigation to evaluate the safety and efficacy of a multidisciplinary digital therapeutics in patients with patellofemoral pain syndrome.
Park TH, Yoon C, Park JH, Lee S, et al · · 2025 · PMID 40890852 · DOI 10.1186/s13063-025-09030-2
Study protocol for a prospective, randomized controlled confirmatory clinical investigation to evaluate the safety and efficacy of a multidisciplinary digital therapeutics in patients with patellofemoral pain syndrome
Park TH, Yoon C, Park JH, Lee S, et al · · 2025 · DOI 10.21203/rs.3.rs-5465840/v1

Verify or expand the search:

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

NCT07318987 — EFFECT OF SAPHENOUS NERVE RELEASE ON PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME · NA · recruiting
NCT06913426 — Effects of Pelvic Tilt Exercises Along With Hip and Knee Focused Exercises on Patients With Patellofemoral Pain Syndrome · NA · active not recruiting
NCT06875804 — Compressive Myofascial Release of the Vastus Lateralis on Lateral Patellar Tracking in Patellofemoral Pain Syndrome · NA · recruiting
NCT06598618 — Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome. · NA · recruiting
NCT06566950 — BFR Training on Muscle Morphology · NA · recruiting

Other EverEx Inc. trials

Trials by the same sponsor.

NCT05940025 — Multidisciplinary Digital Therapeutics of Chronic Lower Back Pain Versus Usual Care · NA · completed
NCT05614583 — Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06260865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by EverEx Inc.
Last refreshed: 23 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06260865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing